tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cantargia AB Appoints Dr. Hilde Steineger as New CEO
PremiumCompany AnnouncementsCantargia AB Appoints Dr. Hilde Steineger as New CEO
2M ago
Cantargia AB to Release H1 2025 Interim Report with Investor Presentation
Premium
Company Announcements
Cantargia AB to Release H1 2025 Interim Report with Investor Presentation
3M ago
Cantargia Reports Preliminary Phase 2 Results for Nadunolimab in TNBC
Premium
Company Announcements
Cantargia Reports Preliminary Phase 2 Results for Nadunolimab in TNBC
3M ago
Cantargia’s CAN10 Antibody Shows Promise in Inhibiting Vascular Inflammation
PremiumCompany AnnouncementsCantargia’s CAN10 Antibody Shows Promise in Inhibiting Vascular Inflammation
5M ago
Cantargia AB Announces Key Resolutions from Annual General Meeting
Premium
Company Announcements
Cantargia AB Announces Key Resolutions from Annual General Meeting
5M ago
Cantargia AB’s Promising Interim Report for Early 2025
Premium
Company Announcements
Cantargia AB’s Promising Interim Report for Early 2025
6M ago
Cantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immunosuppression
PremiumCompany AnnouncementsCantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immunosuppression
6M ago
Cantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immune Suppression
Premium
Company Announcements
Cantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immune Suppression
6M ago
Cantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immunosuppression
Premium
Company Announcements
Cantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immunosuppression
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100